Category: Regulatory Files

G2S2 Capital Inc. Files Proxy Circular for Nomination of Two Independent Trustees at the Upcoming Annual Meeting of Unitholders of Slate Office REIT

HALIFAX, NS, April 17, 2024 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces today that its wholly-owned subsidiary, Armco Alberta Inc. (the “Concerned Unitholder”), has filed and commenced mailing of a proxy circular (the “Circular”) and BLUE form of proxy for the nomination of two highly-experienced and independent trustees to be elected to the board of trustees of Slate Office REIT (the “REIT”) at the upcoming annual meeting of unitholders of the REIT (the “Meeting”) to be held at 11:30 a.m. (EDT) on May 3, 2024.

Continue Reading

G2S2 CAPITAL INC. ANNOUNCES INCREASED INVESTMENT IN WESTERN ENERGY SERVICES CORP.

HALIFAX, NSMarch 1, 2024 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that it has acquired ownership of, and control over, an additional 698,700 common shares of Western Energy Services Corp. (“Western”).

Continue Reading

G2S2 CAPITAL INC. ANNOUNCES INCREASED INVESTMENT IN MORGUARD REAL ESTATE INVESTMENT TRUST

HALIFAX, NS, Feb. 23, 2024 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that its wholly owned subsidiary has acquired ownership of, and control over, an additional 152,900 trust units (“Units”) of Morguard Real Estate Investment Trust (“Morguard REIT”).

Continue Reading

G2S2 CAPITAL INC. ANNOUNCES INCREASED INVESTMENT IN KNIGHT THERAPEUTICS INC.

HALIFAX, NSJan. 31, 2024 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that its wholly owned subsidiary has acquired an additional 147,000 common shares of Knight Therapeutics Inc. (“Knight”), representing approximately 0.14% of the outstanding common shares of Knight. G2S2’s wholly owned subsidiary, Armco Alberta Inc., acquired the common shares on January 31st, 2024, through the facilities of the Toronto Stock Exchange at a price of $5.35 per share (the “Acquisition”).

Continue Reading

G2S2 CAPITAL INC. ANNOUNCES INVESTMENT IN MORGUARD CORPORATION

HALIFAX, NSNov. 15, 2023 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that it has acquired ownership of, and control over, 28,400 common shares (“Shares”) of Morguard Corporation (“Morguard”).

Continue Reading

G2S2 CAPITAL INC. FILES EARLY WARNING REPORT FOR INVESTMENT IN CALFRAC WELL SERVICES LTD.

HALIFAX, NS, Nov. 13, 2023 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that its wholly owned subsidiary has acquired 5,300 warrants to purchase common shares of Calfrac Well Services Ltd. (“Calfrac”).

Continue Reading

G2S2 CAPITAL INC. ANNOUNCES INVESTMENT IN MORGUARD REAL ESTATE INVESTMENT TRUST

HALIFAX, NS, Aug. 15, 2023 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces that its wholly owned subsidiary has acquired ownership of, and control over, 50,000 trust units (“Units”) of Morguard Real Estate Investment Trust (“Morguard REIT”).

Continue Reading

G2S2 CAPITAL INC. ANNOUNCES INCREASED INVESTMENT IN SLATE OFFICE REIT

HALIFAX, NS, May 31, 2023 /CNW/ – G2S2 Capital Inc. (“G2S2”), announces that its wholly owned subsidiary has acquired ownership of, and control over, $373,000 principal amount of 5.50% convertible unsecured subordinated debentures of Slate Office REIT (“Slate Office”).

Continue Reading

G2S2 CAPITAL INC. ANNOUNCES INCREASED INVESTMENT IN CLARKE INC.

HALIFAX, NS, April 20, 2023 /CNW/ – G2S2 Capital Inc. (“G2S2”), announces that it has acquired ownership of, and control over, an additional 46,300 common shares of Clarke Inc. (“Clarke”), representing 0.33% of the outstanding common shares of Clarke (“Common Shares”). G2S2 acquired the Common Shares on April 20, 2023, through the facilities of the Toronto Stock Exchange at a price of $12.05 per share (the “Acquisition”).

Continue Reading

G2S2 CAPITAL INC. ANNOUNCES INVESTMENT IN KNIGHT THERAPEUTICS INC.

HALIFAX, NS, March 23, 2023 /CNW/ – G2S2 Capital Inc. (“G2S2”) announces today that its wholly owned subsidiary has increased its ownership of Knight Therapeutics Inc. (“Knight”) to over 10% of Knight’s outstanding common shares.

Continue Reading
Scroll to top